181 related articles for article (PubMed ID: 18565681)
1. Inhalation of divalent and trivalent manganese mixture induces a Parkinson's disease model: immunocytochemical and behavioral evidences.
Ordoñez-Librado JL; Gutierrez-Valdez AL; Colín-Barenque L; Anaya-Martínez V; Díaz-Bech P; Avila-Costa MR
Neuroscience; 2008 Jul; 155(1):7-16. PubMed ID: 18565681
[TBL] [Abstract][Full Text] [Related]
2. L-DOPA treatment reverses the motor alterations induced by manganese exposure as a Parkinson disease experimental model.
Ordoñez-Librado JL; Anaya-Martinez V; Gutierrez-Valdez AL; Montiel-Flores E; Corona DR; Martinez-Fong D; Avila-Costa MR
Neurosci Lett; 2010 Mar; 471(2):79-82. PubMed ID: 20079802
[TBL] [Abstract][Full Text] [Related]
3. Manganese mixture inhalation is a reliable Parkinson disease model in rats.
Sanchez-Betancourt J; Anaya-Martínez V; Gutierrez-Valdez AL; Ordoñez-Librado JL; Montiel-Flores E; Espinosa-Villanueva J; Reynoso-Erazo L; Avila-Costa MR
Neurotoxicology; 2012 Oct; 33(5):1346-55. PubMed ID: 22975423
[TBL] [Abstract][Full Text] [Related]
4. Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson's disease in mice.
Iancu R; Mohapel P; Brundin P; Paul G
Behav Brain Res; 2005 Jul; 162(1):1-10. PubMed ID: 15922062
[TBL] [Abstract][Full Text] [Related]
5. Manganese inhalation as a Parkinson disease model.
Ordoñez-Librado JL; Anaya-Martínez V; Gutierrez-Valdez AL; Colín-Barenque L; Montiel-Flores E; Avila-Costa MR
Parkinsons Dis; 2010 Dec; 2011():612989. PubMed ID: 21209715
[TBL] [Abstract][Full Text] [Related]
6. Basal Ganglia accumulation and motor assessment following manganese chloride exposure in the C57BL/6 mouse.
Dodd CA; Ward DL; Klein BG
Int J Toxicol; 2005; 24(6):389-97. PubMed ID: 16393931
[TBL] [Abstract][Full Text] [Related]
7. Generation of a alpha-synuclein-based rat model of Parkinson's disease.
Recchia A; Rota D; Debetto P; Peroni D; Guidolin D; Negro A; Skaper SD; Giusti P
Neurobiol Dis; 2008 Apr; 30(1):8-18. PubMed ID: 18313315
[TBL] [Abstract][Full Text] [Related]
8. Assessment of bioaccumulation, neuropathology, and neurobehavior following subchronic (90 days) inhalation in Sprague-Dawley rats exposed to manganese phosphate.
Normandin L; Carrier G; Gardiner PF; Kennedy G; Hazell AS; Mergler D; Butterworth RF; Philippe S; Zayed J
Toxicol Appl Pharmacol; 2002 Sep; 183(2):135-45. PubMed ID: 12387753
[TBL] [Abstract][Full Text] [Related]
9. Persistent penetration of MPTP through the nasal route induces Parkinson's disease in mice.
Rojo AI; Montero C; Salazar M; Close RM; Fernández-Ruiz J; Sánchez-González MA; de Sagarra MR; Jackson-Lewis V; Cavada C; Cuadrado A
Eur J Neurosci; 2006 Oct; 24(7):1874-84. PubMed ID: 17067291
[TBL] [Abstract][Full Text] [Related]
10. Intrastriatal manganese chloride exposure causes acute locomotor impairment as well as partial activation of substantia nigra GABAergic neurons.
Yang Y; An J; Wang Y; Luo W; Wang W; Mei X; Wu S; Chen J
Environ Toxicol Pharmacol; 2011 Jan; 31(1):171-8. PubMed ID: 21787683
[TBL] [Abstract][Full Text] [Related]
11. Uptake, distribution and behavioral effects of inhalation exposure to manganese (MnO2) in the adult mouse.
Morganti JB; Lown BA; Stineman CH; D'Agostino RB; Massaro EJ
Neurotoxicology; 1985; 6(1):1-15. PubMed ID: 3873032
[TBL] [Abstract][Full Text] [Related]
12. PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease.
Schintu N; Frau L; Ibba M; Caboni P; Garau A; Carboni E; Carta AR
Eur J Neurosci; 2009 Mar; 29(5):954-63. PubMed ID: 19245367
[TBL] [Abstract][Full Text] [Related]
13. Chronic organic manganese administration in the rat does not damage dopaminergic nigrostriatal neurons.
Yong VW; Perry TL; Godolphin WJ; Jones KA; Clavier RM; Ito M; Foulks JG
Neurotoxicology; 1986; 7(1):19-24. PubMed ID: 2872639
[TBL] [Abstract][Full Text] [Related]
14. Involvement of striatal lipid peroxidation and inhibition of calcium influx into brain slices in neurobehavioral alterations in a rat model of short-term oral exposure to manganese.
Avila DS; Gubert P; Fachinetto R; Wagner C; Aschner M; Rocha JB; Soares FA
Neurotoxicology; 2008 Nov; 29(6):1062-8. PubMed ID: 18778733
[TBL] [Abstract][Full Text] [Related]
15. Repeated intranigral MPTP administration: a new protocol of prolonged locomotor impairment mimicking Parkinson's disease.
Reksidler AB; Lima MM; Dombrowski P; Andersen ML; Zanata SM; Andreatini R; Tufik S; Vital MA
J Neurosci Methods; 2008 Jan; 167(2):268-77. PubMed ID: 17931705
[TBL] [Abstract][Full Text] [Related]
16. SK channel function regulates the dopamine phenotype of neurons in the substantia nigra pars compacta.
Aumann TD; Gantois I; Egan K; Vais A; Tomas D; Drago J; Horne MK
Exp Neurol; 2008 Oct; 213(2):419-30. PubMed ID: 18680743
[TBL] [Abstract][Full Text] [Related]
17. [The comparison of neurobehavioral changes and impaired locations between the mouse model of manganism and Parkinson's disease].
Dou CS; Zhi CN; Liu WL; Fu JL; Yao BY
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2018 Feb; 36(2):84-90. PubMed ID: 29699003
[No Abstract] [Full Text] [Related]
18. Compromised circadian function in Parkinson's disease: enucleation augments disease severity in the unilateral model.
Willis GL; Kelly AM; Kennedy GA
Behav Brain Res; 2008 Nov; 193(1):37-47. PubMed ID: 18547659
[TBL] [Abstract][Full Text] [Related]
19. Targeted overexpression of the parkin substrate Pael-R in the nigrostriatal system of adult rats to model Parkinson's disease.
Dusonchet J; Bensadoun JC; Schneider BL; Aebischer P
Neurobiol Dis; 2009 Jul; 35(1):32-41. PubMed ID: 19348945
[TBL] [Abstract][Full Text] [Related]
20. Interaction of curcumin with manganese may compromise metal and neurotransmitter homeostasis in the hippocampus of young mice.
Schmitz AE; de Oliveira PA; de Souza LF; da Silva DG; Danielski S; Santos DB; de Almeida EA; Prediger RD; Fisher A; Farina M; Dafre AL
Biol Trace Elem Res; 2014 Jun; 158(3):399-409. PubMed ID: 24723215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
